Sterling Drug (Malaya) S/B is an enterprise in Malaysia, with the main office in Ampang. It operates in the Medicinal and Botanical Manufacturing industry. The enterprise was incorporated on March 03, 1962. In 2023, the company reported a net sales revenue increase of 33.78%. There was a total growth of 70.52% in Sterling Drug (Malaya) S/B’s total assets over the same period. The net profit margin of Sterling Drug (Malaya) S/B decreased by 1.39% in 2023.
Headquarters
Lot 89 Jalan Enggang, Ampang/Hulu Kelang Industrial Estate
Ampang; Selangor;
Postal Code: 68000
Contact Details: Purchase the Sterling Drug (Malaya) S/B report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service